Baxter announces FDA clearance of home dialysis system
DEERFIELD -- Baxter International Inc. Monday announced U.S. Food and Drug Administration clearance of an automated home dialysis system with remote connectivity. Baxter's Homechoice Claria system combines a simple user interface with the benefits of Sharesource, the only two-way remote patient management platform for patients on peritoneal dialysis in the U.S.
Homechoice Claria system has been cleared for both adult and pediatric patients.
"Our goal remains to expand accessibility to home-based therapy for U.S. patients with kidney failure," said Gavin Campbell, general manager of Baxter's U.S. Renal Care business.
The clearance follows the recent finalization of the company's End-Stage Renal Disease Treatment Choices payment model, which aims to significantly increase the number of new patients with kidney failure who receive home dialysis and/or organ transplants, Baxter said.